Antigen-specific T-cell responses of leprosy patients.
The identification of human T-cell antigens of Mycobacterium leprae could improve treatment and help to disrupt the transmission of leprosy by directing diagnosis and vaccine programs. This study screened a panel of M. leprae recombinant proteins for T-cell recall responses, measured by gamma interferon (IFN-gamma) production, among leprosy patients. After initial studies using peripheral blood mononuclear cells from leprosy patients, we transitioned our studies to simple whole-blood assays (WBA), which are more applicable in field or clinical settings. T-cell responses generated in WBA using blood from individuals in Goiânia, Brazil, demonstrated that several M. leprae antigens (ML0276, ML0840, ML1623, ML2044, and 46f) elicited >0.5 IU/ml IFN-gamma, and these proteins were classified as immunogenic and leprosy specific. Several of these individual antigens were recognized by cells from >60% of Brazilian paucibacillary (PB) leprosy patients, and ML0276, ML0840, ML1623, and 46f complemented each other such that 82% of PB patients had strong (>1.25 IU/ml IFN-gamma) responses to at least one of these proteins. These proteins were also recognized by cells from a significant proportion of the household contacts of multibacillary leprosy patients, but in contrast, few responses were observed in active tuberculosis patients or healthy control groups from areas of endemicity. Our results indicate several potential candidate antigens which may be useful for either leprosy diagnosis or vaccination and demonstrate the utility of leprosy WBA that can be applied broadly in clinical or field settings.
Duthie
Malcolm S
MS
Infectious Disease Research Institute, Seattle, WA 98104, USA. mduthie@idri.org
Goto
Wakako
W
Ireton
Greg C
GC
Reece
Stephen T
ST
Sampaio
Lucas H
LH
Grassi
A B
AB
Sousa
Ana Lucia M
AL
Martelli
Celina M T
CM
Stefani
Mariane M A
MM
Reed
Steven G
SG
D000293:Adolescent; D000328:Adult; D000368:Aged; D000942:Antigens, Bacterial / Q000276:immunology*; D001426:Bacterial Proteins / Q000276:immunology; D001938:Brazil; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D007918:Leprosy / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009166:Mycobacterium leprae / Q000276:immunology*; D011994:Recombinant Proteins / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D011994:Recombinant Proteins; D007371:Interferon-gamma
Infect Immun. 2006 Jan;74(1):175-82
16368971
Infect Immun. 2003 Mar;71(3):1596-8
12595485
Lancet Infect Dis. 2004 Dec;4(12):761-76
15567126
J Clin Microbiol. 2003 May;41(5):1991-5
12734239
Nature. 2001 Feb 22;409(6823):1007-11
11234002
Indian J Lepr. 1998 Oct-Dec;70(4):369-88
10189587
J Immunol. 2005 Dec 15;175(12):7930-8
16339528
Int J Lepr Other Mycobact Dis. 1999 Jun;67(2):119-28
10472363
Scand J Immunol. 1999 Nov;50(5):541-9
10564558
Lepr Rev. 1994 Sep;65(3):175-80
8942148
Expert Rev Anti Infect Ther. 2005 Dec;3(6):981-93
16307510
Int J Lepr Other Mycobact Dis. 1999 Sep;67(3):279-86
10575407
Clin Microbiol Rev. 2006 Apr;19(2):338-81
16614253
Hum Immunol. 2006 Jun;67(6):439-45
16728267
Clin Exp Immunol. 2007 Nov;150(2):210-6
17937676
Int J Lepr Other Mycobact Dis. 2001 Mar;69(1):1-12
11480310
Lepr Rev. 2003 Sep;74(3):196-205
14577464
Clin Vaccine Immunol. 2007 Nov;14(11):1400-8
17898185
Infect Immun. 2005 Sep;73(9):5636-44
16113281
Lepr Rev. 2006 Mar;77(1):48-61
16715690
Expert Rev Mol Diagn. 2006 Sep;6(5):663-77
17009902
Lancet. 1992 Feb 22;339(8791):446-50
1346818
Clin Exp Immunol. 1999 May;116(2):263-9
10337017
Clin Vaccine Immunol. 2006 Mar;13(3):333-40
16522774
Clin Vaccine Immunol. 2008 Mar;15(3):522-33
18199740
FEMS Immunol Med Microbiol. 1999 Jul 15;24(4):405-9
10435759
Microbes Infect. 2006 Jul;8(8):2270-6
16797206
Int J Tuberc Lung Dis. 1998 Jun;2(6):441-2
9626599
Clin Exp Immunol. 1991 Apr;84(1):103-8
2015700